Literature DB >> 21616107

Lactose characteristics and the generation of the aerosol.

Gabrielle Pilcer1, Nathalie Wauthoz, Karim Amighi.   

Abstract

The delivery efficiency of dry-powder products for inhalation is dependent upon the drug formulation, the inhaler device, and the inhalation technique. Dry powder formulations are generally produced by mixing the micronised drug particles with larger carrier particles. These carrier particles are commonly lactose. The aerosol performance of a powder is highly dependent on the lactose characteristics, such as particle size distribution and shape and surface properties. Because lactose is the main component in these formulations, its selection is a crucial determinant of drug deposition into the lung, as interparticle forces may be affected by the carrier-particle properties. Therefore, the purpose of this article is to review the various grades of lactose, their production, and the methods of their characterisation. The origin of their adhesive and cohesive forces and their influence on aerosol generation are described, and the impact of the physicochemical properties of lactose on carrier-drug dispersion is discussed in detail. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616107     DOI: 10.1016/j.addr.2011.05.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  17 in total

1.  Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.

Authors:  Cassandra Ming Shan Leung; Zhenbo Tong; Qi Tony Zhou; John Gar Yan Chan; Patricia Tang; Siping Sun; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2016-05-09       Impact factor: 4.009

Review 2.  Administration of dry powders during respiratory supports.

Authors:  Wei-Ren Ke; Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Patricia Tang; Lan Chen; Donghao Chen; Hak-Kim Chan
Journal:  Ann Transl Med       Date:  2021-04

3.  Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.

Authors:  Nivedita Shetty; Lingfei Zeng; Sharad Mangal; Haichen Nie; Matthew R Rowles; Rui Guo; Youngwoo Han; Joon Hyeong Park; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

Review 4.  Lactose engineering for better performance in dry powder inhalers.

Authors:  Yahya Rahimpour; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2012-08-15

5.  Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.

Authors:  Nivedita Shetty; Heejun Park; Dmitry Zemlyanov; Sharad Mangal; Sonal Bhujbal; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2018-04-18       Impact factor: 5.875

6.  Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.

Authors:  Manoel Ortiz; Denise Soledade Jornada; Adriana Raffin Pohlmann; Sílvia Stanisçuaski Guterres
Journal:  AAPS PharmSciTech       Date:  2015-02-05       Impact factor: 3.246

7.  Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.

Authors:  Yingjie Chen; Shen Yan; Shengyu Zhang; Quanyi Yin; Xiao Dong Chen; Winston Duo Wu
Journal:  AAPS PharmSciTech       Date:  2022-08-02       Impact factor: 4.026

8.  Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis.

Authors:  Peng Lu; Jiawei Li; Chuanxin Liu; Jian Yang; Hui Peng; Zhifeng Xue; Zhidong Liu
Journal:  Asian J Pharm Sci       Date:  2022-04-30       Impact factor: 9.273

9.  Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.

Authors:  Thi-Tram Nguyen; Eun-Jin Yi; Kyu-Mok Hwang; Cheol-Hee Cho; Chun-Woong Park; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

10.  Empirical modeling of the fine particle fraction for carrier-based pulmonary delivery formulations.

Authors:  Adam Pacławski; Jakub Szlęk; Raymond Lau; Renata Jachowicz; Aleksander Mendyk
Journal:  Int J Nanomedicine       Date:  2015-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.